Credit Suisse’s Organogenesis Holdings ORGO Stock Holding History

Credit Suisse’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,482	Closed	-$161K	–	3122
2023 Q3	$161K	Buy	50,482 +10,482	+26%	+$33.3K	﹤0.01%	3060
2023 Q2	$133K	Sell	40,000 -44,248	-53%	-$131K	﹤0.01%	3124
2023 Q1	$179K	Buy	84,248 +15	+0%	+$37	﹤0.01%	3137
2022 Q4	$227K	Sell	84,233 -28,621	-25%	-$83.5K	﹤0.01%	3143
2022 Q3	$365K	Buy	112,854 +19,893	+21%	+$89.9K	﹤0.01%	2981
2022 Q2	$454K	Buy	92,961 +3,330	+4%	+$20.5K	﹤0.01%	2908
2022 Q1	$683K	Buy	89,631 +2,070	+2%	+$16K	﹤0.01%	2793
2021 Q4	$809K	Buy	87,561 +69,891	+396%	+$742K	﹤0.01%	3486
2021 Q3	$252K	Sell	17,670 -10,949	-38%	-$170K	﹤0.01%	4146
2021 Q2	$475K	Buy	+28,619	New	+$533K	﹤0.01%	3878

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Credit Suisse's ORGO Position: Q4 2023 in Review

Credit Suisse sold out of Organogenesis Holdings (ORGO) in Q4 2023, closing a stake of 50,482 shares — an estimated $161K sold.

Credit Suisse first reported a position in ORGO in Q2 2021 and held it in 10 quarters. The position peaked at $809K in Q4 2021. 108 funds tracked by Wall St. Rank hold ORGO as of Q4 2023.

Credit Suisse reported no remaining Organogenesis Holdings position as of Q4 2023 after selling out during the quarter.
Credit Suisse sold 50,482 Organogenesis Holdings shares in Q4 2023, an estimated $161K.
Credit Suisse first reported a position in Organogenesis Holdings in Q2 2021 and held it in 10 quarters.
Credit Suisse's Organogenesis Holdings position peaked at $809K in Q4 2021.
108 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.